SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-19-000860
Filing Date
2019-02-08
Accepted
2019-02-08 18:32:46
Documents
2
Period of Report
2019-02-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 11145
2 POA nicholasasaccomanopoa.txt EX-24 1212
  Complete submission text file 0001562180-19-000860.txt   13713
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Issuer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 303-381-6600
Saccomano Nicholas A (Reporting) CIK: 0001609284 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-16633 | Film No.: 19581405